医学
自身免疫性疾病
透皮
免疫系统
疾病
临床试验
不利影响
免疫学
自身免疫
重症监护医学
生物信息学
药物输送
评论文章
疾病治疗
免疫疗法
作者
Ying Chen,Yanping Fu,Xinyu Wen,Minglong Chen,Linghui Dian,Tingting Peng,Chuanbin Wu,Chao Lu,Guilan Quan
标识
DOI:10.1016/j.apsb.2026.01.003
摘要
Autoimmune diseases are characterized by an aberrant immune response directed against the body’s own components, leading to immune dysfunction and loss of tolerance. This ultimately results in tissue damage and organ impairment. Despite the availability of a range of pharmacological agents for the treatment of autoimmune diseases, numerous challenges still remain. These include reduced bioavailability, first-pass metabolism, severe adverse effects, and low patient compliance associated with oral or injectable routes of administration. Microneedles (MNs) based delivery systems offer a promising alternative for transdermal drug administration, as they can circumvent the aforementioned limitations via the generation of microchannels in the skin in a minimally invasive manner with low pain. This review examines the applications and recent advances in MN systems for treating autoimmune diseases, focusing on six key areas: an overview of autoimmune diseases, current treatment modalities, an introduction to MNs, advantages of MNs for autoimmune disease treatment, advancements in MN-mediated therapies for diverse autoimmune diseases, and relevant MN technologies currently undergoing clinical trials. Additionally, it considers the prospective future advancements of MN systems in the management of autoimmune diseases. This review explores MN systems in autoimmune disease treatment, covering disease overview, treatment options, MN advantages, advancements, and clinical trial technologies.
科研通智能强力驱动
Strongly Powered by AbleSci AI